Jodi Layton, MD
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Avelumab Plus 2nd-generation ADT in African American Subjects With mCRPC (NCT03770455) | Jodi Layton, MD | 2019-01-25 |
Track Jodi Layton, MD automatically
Every clearance here is in the API, with alerts when new ones post.